Your browser doesn't support javascript.
loading
Safety and tolerability of combination therapy with pirfenidone and nintedanib for idiopathic pulmonary fibrosis: A multicenter retrospective observational study in Japan.
Hisata, Shu; Bando, Masashi; Homma, Sakae; Kataoka, Kensuke; Ogura, Takashi; Izumi, Shinyu; Sakamoto, Susumu; Watanabe, Kizuku; Saito, Yoshinobu; Shimizu, Yasuo; Kato, Motoyasu; Nishioka, Yasuhiko; Hara, Hiromichi; Waseda, Yuko; Tanino, Yoshinori; Yatera, Kazuhiro; Hashimoto, Seishu; Mukae, Hiroshi; Inase, Naohiko.
Affiliation
  • Hisata S; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan.
  • Bando M; Division of Pulmonary Medicine, Department of Medicine, Jichi Medical University, 3311-1 Yakushiji, Shimotsuke-shi, Tochigi, 329-0498, Japan. Electronic address: bando034@jichi.ac.jp.
  • Homma S; Department of Advanced and Integrated Interstitial Lung Diseases Research, School of Medicine, Toho University, 5-21-16 Omorinishi, Ota-ku, Tokyo, 143-8540, Japan.
  • Kataoka K; Department of Respiratory Medicine and Allergy, Tosei General Hospital, 160 Nishioiwake-cho, Seto, Aichi, 489-8642, Japan.
  • Ogura T; Division of Respiratory Medicine, Kanagawa Cardiovascular and Respiratory Center, 6-16-1 Tomioka-higashi, Kanazawa-ku, Yokohama, 236-0051, Japan.
  • Izumi S; Department of Respiratory Medicine, National Center for Global Health and Medicine, 1-21-1 Toyama Shinjuku-ku, Tokyo, 162-8655, Japan.
  • Sakamoto S; Department of Respiratory Medicine, Toho University Omori Medical Center, 5-21-16 Omorinishi, Ota-ku, Tokyo, 143-8540, Japan.
  • Watanabe K; Department of Respiratory Medicine, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto, 606-8501, Japan.
  • Saito Y; Department of Pulmonary Medicine and Oncology, Graduate School of Medicine, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 113-8602, Japan.
  • Shimizu Y; Department of Pulmonary Medicine and Clinical Immunology, Dokkyo Medical University School of Medicine, 880 Kitakobayashi, Mibu, Shimotsugagun, Tochigi, 321-0293, Japan.
  • Kato M; Department of Respiratory Medicine, Juntendo University Graduate School of Medicine, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.
  • Nishioka Y; Graduate School of Biomedical Sciences, Tokushima University, Department of Respiratory Medicine and Rheumatology, 3-18-15, Kuramoto-cho, Tokushima, 770-8503, Japan.
  • Hara H; Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8, Nishi-Shimbashi, Minato-ku, Tokyo, 105-8461, Japan.
  • Waseda Y; Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, 23-3, Matsuokashimoaizuki, Eiheiji-cho, Yoshida-gun, Fukui, 910-1193, Japan.
  • Tanino Y; Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, 1 Hikariga-oka, Fukushima, 960-1295, Japan.
  • Yatera K; Department of Respiratory Medicine, University of Occupational and Environmental Health, 1-1, Iseigaoka, Kitakyushu, 807-8555, Japan.
  • Hashimoto S; Department of Respiratory Medicine, Tenri Hospital, 200, Mishima-cho, Tenri, 632-8552, Japan.
  • Mukae H; Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, 1-12-4 Sakamoto, Nagasaki, 852-8523, Japan.
  • Inase N; Department of Respiratory Medicine, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Respir Investig ; 59(6): 819-826, 2021 Nov.
Article in En | MEDLINE | ID: mdl-33994347

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Idiopathic Pulmonary Fibrosis Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Respir Investig Year: 2021 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridones / Idiopathic Pulmonary Fibrosis Type of study: Observational_studies / Risk_factors_studies Limits: Humans Country/Region as subject: Asia Language: En Journal: Respir Investig Year: 2021 Document type: Article Affiliation country: Country of publication: